Hims & Hers offer phone support at 1-800-368-0038, Monday through Friday, 9 a.m.5 p.m
Email Human Email support at [email protected]
12 A recent meta-analysis of 26,894 obese participants without diabetes showed that semaglutide use increased the risk of gallbladder stones by 2.6 times, while this risk was not evident for tirzepatide
Low levels can lead to fatigue, brain fog, mood changes, and anemia
Related topics Topic Replies Views Activity New weight loss drugs....a overview MBBS 2 23 July 8, 2026 Drug of the Week: Science Behind Weight Loss Drug (SEMAGLUTIDE) General 10 66 May 11, 2026 Semaglutide: A Breakthrough GLP-1 Receptor Agonist in Diabetes and Obesity Management Pharmacy mbbs , medical , futuredoctors 3 50 October 27, 2025 Semaglutide : Drug Profile Pharmacy 3 39 June 30, 2026 Updates In Diabetes Management : GLP-1 Agonists VS SGLT-2 Inhibitors Pharmacy 0 21 March 7, 2026 Home Categories Guidelines Terms of Service Privacy Policy Powered by Discourse, best viewed with JavaScript enabled
For Wegovy, Saxenda, and Zepbound, this means having a BMI of 30, or a BMI of 27 or over and a weight-related health condition
